Get started
Author

Marco Guarracino

Observed names: M. Guarracino, M., Guarracino
ORCID: 0000-0003-3956-8405
Observed ORCID: 0000-0003-3956-8405
OpenAlex ID: A5077922378
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
2023 · Alessandro Vitale, Giuseppe Cabibbo, et al. · The Lancet Oncology · 229
Conventional vs. DEB vs. DSM: Which technique for palliative TACE in intermediate-stage HCC? Results on 70 patients in terms of efficacy and tolerance
2025 · Francesco Giurazza, Claudio Carrubba, et al. · La radiologia medica · 7
Conversion Ability of Immunotherapy in Hepatocellular Carcinoma: Insights from the International Converse Study
2025 · Alessandro Vitale, Jung Sun Kim, et al. · Liver Cancer · 7
PDF
Incidence of HCC recurrence after DAA treatment for HCV in a multicentre Italian cohort study
2020 · Maria Guarino, Giovan Giuseppe Di Costanzo, et al. · Liver Cancer International · 5
PDF
Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: A pilot study
2018 · G.G. Di Costanzo, C.K.Y. Ng, et al. · Digestive and Liver Disease · 4
HCC recurrence after DAA treatment in HCV patients
2018 · M. Guarino, D. Bruzzese, et al. · Digestive and Liver Disease · 3
Predictive scores for hepatocellular carcinoma: a race with no winners?
2020 · Raffaella Tortora, Marco Guarracino, et al. · Annals of Translational Medicine · 2
PDF
Liver Tumors Laser Ablation
2019 · Giovan Giuseppe Di Costanzo, Raffaella Tortora, et al. · Springer eBooks · 2
Clinical and Radiological Outcomes Comparison of Degradable Starch Microspheres TACE with Idarubicin vs. Epirubicin Protocol in Patients with HCC
2026 · Francesco Giurazza, Pietro Roccatagliata, et al. · Diagnostics · 1
PDF
Thermal ablation of large unresectable hepatocellular carcinoma in cirrhotic patients
2018 · Giovan Giuseppe Di Costanzo, Raffaella Tortora, et al. · Hepatoma Research · 1
PDF
Oc.06.2 Helicobacter Pylori Infection and Obesity: Is There a Link?
2014 · A. Rocco, C. Sgamato, et al. · Digestive and Liver Disease · 1
Oc.12.2 Gluten-free Diet Increases Fat Mass and Modifies Serum Adiponectin Levels in Adult Celiac Disease Patients
2014 · A. Rocco, M. Sanduzzi Zamparelli, et al. · Digestive and Liver Disease · 1
PDF
Oc.03.5 Bifidobacterium Longum Up-regulates Ppar-gamma and Ppar-alpha Levels in Hepg2 Hepatic Cancer Cell Line
2013 · A. Cianflone, M. Sanduzzi Zamparelli, et al. · Digestive and Liver Disease · 1
PDF
Acnmd26-306: Systemic Inflammatory Markers Predict Overall Survival and Therapeutic Response in Immunotherapy-treated Hepatocellular Carcinoma
2026 · Alba Rocco, Costantino Sgamato, et al. · Digestive and Liver Disease
Type 2 diabetes combined with portal vein tumor thrombosis worsens prognosis in patients with hepatocellular carcinoma
2022 · Debora Angrisani, Marco Guarracino, et al. · Journal of Hepatology
SAT-461-HCC recurrence after DAA treatment in HCV patients
2019 · Maria Guarino, Dario Bruzzese, et al. · Journal of Hepatology
Oc.07.4 Hcc Recurrence After Daa Treatment in Hcv Patients
2019 · M. Guarino, D. Bruzzese, et al. · Digestive and Liver Disease
Oc.21.5 Lar Octreotide Is Effective in Controlling Recurrent Bleeding From Gastrointestinal Angiodysplasias: a Retrospective Study of 98 Cases
2014 · D. Compare, C. Sgamato, et al. · Digestive and Liver Disease
P.11.14 Locoregional Treatments (pei and Rfta) of Hepatocellular Carcinoma Do Not Affect Liver Function in Cirrhotic Patients
2013 · P. Coccoli, M. Guarracino, et al. · Digestive and Liver Disease
PDF
Works count: 20
Citation count: 264
H-index: 4
I10-index: 1
Year
Topic
Type